Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.verified

NWRN.SW

Price:

$7.71

Market Cap:

$164.02M

Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia. It also develops Evenamide for Schizophrenia and treatment resistant schizophrenia; and Ralfinamide for orphan indication in neuropathic pain. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.[Read more]

Industry

Biotechnology

IPO Date

2006-12-12

Stock Exchange

SIX

Ticker

NWRN.SW

The PE Ratio as of September 2024 (TTM) for Newron Pharmaceuticals S.p.A. (NWRN.SW) is -8.97

According to Newron Pharmaceuticals S.p.A.’s latest financial reports and current stock price. The company's current PE Ratio is -8.97. This represents a change of 339.61% compared to the average of -2.04 of the last 4 quarters.

Newron Pharmaceuticals S.p.A. (NWRN.SW) Historical PE Ratio (quarterly & annually)

How has NWRN.SW PE Ratio performed in the past?

The mean historical PE Ratio of Newron Pharmaceuticals S.p.A. over the last ten years is -11.27. The current -8.97 PE Ratio has changed 7.86% with respect to the historical average. Over the past ten years (40 quarters), NWRN.SW's PE Ratio was at its highest in in the June 2017 quarter at 49.13. The PE Ratio was at its lowest in in the September 2012 quarter at -22.15.

Quarterly (TTM)
Annual

Average

-11.27

Median

-6.10

Minimum

-30.56

Maximum

-1.60

Newron Pharmaceuticals S.p.A. (NWRN.SW) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Newron Pharmaceuticals S.p.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 267.08%

Maximum Annual PE Ratio = -1.60

Minimum Annual Increase = -79.26%

Minimum Annual PE Ratio = -30.56

Quarterly (TTM)
Annual
YearPE RatioChange
2023-5.86267.08%
2022-1.60-14.57%
2021-1.8710.63%
2020-1.69-67.29%
2019-5.16-18.51%
2018-6.34-79.26%
2017-30.5668.78%
2016-18.1128.11%
2015-14.14-48.32%
2014-27.3523.28%

Newron Pharmaceuticals S.p.A. (NWRN.SW) Average PE Ratio

How has NWRN.SW PE Ratio performed in the past?

The current PE Ratio of Newron Pharmaceuticals S.p.A. (NWRN.SW) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.11

5-year avg

-3.24

10-year avg

-11.27

Newron Pharmaceuticals S.p.A. (NWRN.SW) PE Ratio vs. Peers

How is NWRN.SW’s PE Ratio compared to its peers?

Newron Pharmaceuticals S.p.A.’s PE Ratio is less than Santhera Pharmaceuticals Holding AG (1.27), greater than Basilea Pharmaceutica AG (-848.94), less than Addex Therapeutics Ltd (-0.59), less than Evolva Holding SA (-0.09), less than Cosmo Pharmaceuticals N.V. (19.22),

Build a custom stock screener for Newron Pharmaceuticals S.p.A. (NWRN.SW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Newron Pharmaceuticals S.p.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Newron Pharmaceuticals S.p.A. (NWRN.SW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Newron Pharmaceuticals S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Newron Pharmaceuticals S.p.A.'s PE Ratio?

How is the PE Ratio calculated for Newron Pharmaceuticals S.p.A. (NWRN.SW)?

What is the highest PE Ratio for Newron Pharmaceuticals S.p.A. (NWRN.SW)?

What is the 3-year average PE Ratio for Newron Pharmaceuticals S.p.A. (NWRN.SW)?

What is the 5-year average PE Ratio for Newron Pharmaceuticals S.p.A. (NWRN.SW)?

How does the current PE Ratio for Newron Pharmaceuticals S.p.A. (NWRN.SW) compare to its historical average?